MAPT and Alzheimer disease: Future research should characterize the other neuropathological facets of this AD model, such as the presence of tau pathology resulting in neurofibrillary tangles, gliosis, and neuronal loss, expanding upon the initial work of Cohen et al.5, to determine its effectiveness at each age-point in modeling the progression of AD.